期刊文献+

血清CA15-3和B-AKP检测在乳腺癌术后骨转移显像诊断中的应用 被引量:9

Application of Measurements of Serum CA15-3 and B-AKP in Diagnosis of Bone Metastasis in Patients with Post-operative Mammary Cancer
下载PDF
导出
摘要 为探讨血清CA15-3和B-AKP在乳腺癌术后骨转移显像诊断中的应用,对92例乳腺癌术后患者的核素骨显像结果、血清CA15-3和B-AKP水平进行回顾性研究。结果显示:①血清CA15-3和B-AKP的值随着骨转移分期的增高而逐步升高,且有显著性差异(P<0.01);②血清CA15-3和B-AKP与骨转移灶的数目呈正相关;③血清CA15-3>25U/mL时,骨转移的阳性率为63.3%,血清CA15-3<25U/mL时,骨转移的阴性预测值为94.5%;血清B-AKP>20U/L时,骨转移的阳性率为59.6%,B-AKP<20U/L时,骨转移的阴性预测值为73.5%;当血清CA15-3<25U/mL同时B-AKP<20U/L时,骨转移的阴性预测值为100%。结论:血清CA15-3和B-AKP测定在乳腺癌术后骨显像诊断中具有重要的应用价值。 To evaluate the diagnosis value of serum CA15-3 and B-AKP measurements in diagnosis of bone metastasis images in patients with post-operative mammary cancer,retrospective study on the bone scan images and serum CA15-3 and bone alkaline phosphatase(B-AKP) levels were performed in 92 patients with confirmed post-operative mammary gland cancer.The results showed that the serum levels of CA15-3 and B-AKP were increased step by step significantly along with the advancement of bone metastatic grading from M0 to M3(P〈0.01).The serum levels of CA15-3 and B-AKP were positively correlated with the number of bone metastasis.The positive rate of bone metastasis was 63.2% with serum CA15-3 more than 25U/mL;and the negative predictive value of bone metastasis was 94.5% with serum CA15-3 less than 25U/mL.The positive rate of bone metastasis was 59.6% with serum B-AKP levels more than 20U/L;and the negative predictive value of bone metastasis was 73.5% with serum B-AKP levels less than 20U/L.The negative predictive value of bone metastasis was 100% with serum CA15-3 less than 25U/mL and serum B-AKP levels less than 20U/L.The combined measurement of the serum CA15-3 and B-AKP levels would play an important role in diagnosis of bone scan images in patients with post-operative mammary cancer.
出处 《标记免疫分析与临床》 CAS 2010年第1期20-22,共3页 Labeled Immunoassays and Clinical Medicine
关键词 乳腺癌 骨转移 骨显像 乳腺癌糖类抗原15-3 骨特异性碱性磷酸酶 Mammary cancer Osseous metastasis Bone imaging CA15-3 B-AKP
  • 相关文献

参考文献8

  • 1余宗林,李中琴.乳腺癌微转移的检测及临床意义[J].临床和实验医学杂志,2009,8(1):134-136. 被引量:8
  • 2胡赟宏,苏光启,叶古祥.乳腺癌患者血清CA15-3的临床价值[J].现代诊断与治疗,2002,13(2):80-82. 被引量:3
  • 3Soloway M S,Hardenman S W, Hiekey D, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan[J]. Cancer. 1988,61: 195.
  • 4Wymenga L, Boomsma J, Groenier K, et al. Routine bone scans in patients with prostate cancer related to serum prostate specific antigen and alkaline phosphatas[J]. BJU Int, 2001,88(3) : 226.
  • 5张友会.现代肿瘤学[M].北京:北京医科大学, 中国协和医科大学联合出版社,1993.153-181.
  • 6O' Dwyer P J,Duffy M J,O' Sullivan F,et al. CEA and CA15-3 in primary and recurrent breast cancer[J].World J Surg, 1990, 14:565.
  • 7Geraghty J G,Coreney E C,Sherry F,et al. CA15-3 in patients with locoregional and metastatic breast carcinoma [ J]. Cancer, 1992, 70:2831.
  • 8申小苏,徐爱乡,顾建兴.骨特异性碱性磷酸酶作为骨转移癌诊断指标的临床评价[J].江苏大学学报(医学版),2002,12(4):373-374. 被引量:10

二级参考文献27

共引文献19

同被引文献96

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部